Drug Development; Inflammation; Monoclonal Antibodies; Oral Biology; Pathophysiology; Protein Function and Structure; Structural Biology; Transgenic organisms
Fellowship, Vascular Biology, Inflammation, University of California, San Diego (2011)
PhD, University of North Carolina (2007)
BS, Biochemistry, Central China Normal Universtiy (1999)
Employment:
Associate Professor, Oral Biology, University at Buffalo (2020-present)
Assistant Professor, Oral Biology, University at Buffalo (2014–2019)
Scientist, Assistant Project Scientist, Cellular and Molecular Medicine, University of California, San Diego School of Medicine (2011–2014)
Awards and Honors:
ASBMR 2019 Annual Meeting Research Team Travel Award (2019)
JBC/Herbert Tabor Young Investigator Award (2012)
Outstanding Poster Award at the Gordon Research Conference, Proteoglycans (2012)
The ASBMB 2012 Thematic Best Poster in Glycobiology, 2012 ASBMB Annual Meeting (2012)
American Heart Association postdoctoral Fellowship (2008)
American Heart Association Predoctoral Fellowship (2005)
Research Expertise:
Bone biology
Glycobiology
Heparan Sulfate
Inflammation
Structural Biology
www.xulab-heparan.org: Lab website
Patents:
Sulfated oligosaccharides decrease sterile inflammation damage in the live A new sulfated heparin sulfate oligosaccharide displays protective effect on drug-induced liver damage. The compound likely inhibits the function of HMGB1, a common protein in regulating immune responses. This discovery can be applied for a wide range of diseases that are caused by over reaction of inflammation responses.
Professional Memberships:
International Association for Dental Research (2023–present)
The American Society for Bone and Mineral Research (2015–present)
American Society for Biochemistry and Molecular Biology (2012–present)
Society for Glycobiology (2009–present)
American Society for Matrix Biology (2008–present)
American Heart Association (2004–present)
Presentations:
"Heparan sulfate is a master regulator of bone remodeling" National Institute of Environmental Health Sciences (2024)
"Heparan sulfate is a master regulator of bone remodeling" Emory School of Medicine (2024)
"Deciphering Heparan sulfate-protein interactions in Bone remodeling and inflammation" (2018)
"Deciphering Heparan sulfate-protein interactions in Bone remodeling" (2017)
"Deciphering Heparan sulfate-protein interactions in Bone remodeling" (2017)
"Heparan sulfate in bone remodeling" (AADR) Buffalo Section, Lunch and Learn Seminar Series; University at Buffalo (2015)
"Heparan sulfate in inflammation and bone remodeling" Inviated talk; Roswell Park Cancer Institute (2015)
"Heparan Sulfate–Dependent Oligomerization of RAGE is essential for signal transduction" Vasculata 2013; North American Vascular Biology Organization (2013)
"Heparan Sulfate–Dependent Oligomerization of RAGE is essential for signal transduction" Gordon Research Conference, Glycobiology; Gordon Research Conference (2013)
"Heparan Sulfate–Dependent Oligomerization of RAGE–a novel target for therapeutic intervention" Invited presentation; School of Pharmacy, University of Arizona (2013)
"Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice" 2012 ASBMB Annual Meeting; ASBMB (2012)
"Heparan Sulfate as a regulator of VEGF-induced vascular permeability" Gordon Research Conference, Vascular Cell Biology; ; Vascular Cell Biology (2009)